Olin (NYSE:OLN) Stock Rating Lowered by Zacks Research

Olin (NYSE:OLN) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Thursday,Zacks.com reports.

Other analysts have also recently issued reports about the stock. Wall Street Zen cut shares of Olin from a “hold” rating to a “sell” rating in a research note on Saturday, January 10th. Citigroup raised their price target on Olin from $21.00 to $24.00 and gave the company a “neutral” rating in a report on Tuesday, January 13th. Mizuho set a $22.00 price objective on Olin in a research report on Friday. KeyCorp cut their target price on Olin from $30.00 to $29.00 and set an “overweight” rating for the company in a research report on Wednesday, October 29th. Finally, Royal Bank Of Canada lifted their target price on Olin from $22.00 to $24.00 and gave the company a “sector perform” rating in a research note on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, Olin has an average rating of “Hold” and a consensus price target of $24.00.

Olin Stock Down 6.8%

NYSE OLN opened at $20.82 on Thursday. The stock’s 50-day moving average price is $21.72 and its 200-day moving average price is $22.03. The company has a market capitalization of $2.38 billion, a P/E ratio of -54.79, a price-to-earnings-growth ratio of 3.31 and a beta of 1.64. The company has a quick ratio of 0.89, a current ratio of 1.56 and a debt-to-equity ratio of 1.49. Olin has a 52 week low of $17.66 and a 52 week high of $30.74.

Olin (NYSE:OLN) last released its earnings results on Thursday, January 29th. The specialty chemicals company reported ($0.58) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.58). Olin had a negative net margin of 0.63% and a negative return on equity of 0.47%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same period in the prior year, the firm posted $0.09 EPS. The firm’s quarterly revenue was down .4% compared to the same quarter last year. On average, equities research analysts predict that Olin will post 1.38 earnings per share for the current year.

Insider Activity

In other news, VP Teresa M. Vermillion sold 4,500 shares of Olin stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $20.86, for a total value of $93,870.00. Following the completion of the transaction, the vice president owned 17,199 shares in the company, valued at approximately $358,771.14. The trade was a 20.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Royal Bank of Canada raised its position in Olin by 20.2% in the 1st quarter. Royal Bank of Canada now owns 85,198 shares of the specialty chemicals company’s stock worth $2,066,000 after purchasing an additional 14,344 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Olin during the 1st quarter worth $32,000. Jones Financial Companies Lllp grew its holdings in Olin by 467.9% during the 1st quarter. Jones Financial Companies Lllp now owns 13,805 shares of the specialty chemicals company’s stock worth $335,000 after acquiring an additional 11,374 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Olin by 57.6% during the first quarter. Goldman Sachs Group Inc. now owns 588,602 shares of the specialty chemicals company’s stock valued at $14,268,000 after purchasing an additional 215,235 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Olin by 6.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 317,472 shares of the specialty chemicals company’s stock valued at $7,696,000 after acquiring an additional 20,047 shares in the last quarter. 88.67% of the stock is owned by hedge funds and other institutional investors.

Olin News Roundup

Here are the key news stories impacting Olin this week:

• Positive Sentiment: Olin is reshaping its chemicals portfolio — management announced a planned closure in Brazil and set a 2026 target for growing its epoxy business, signaling a strategic shift toward higher-value products that could improve margins over time. Olin Reshapes Chemicals Portfolio With Brazil Closure And 2026 Epoxy Goal
• Positive Sentiment: Company reported positive adjusted EBITDA for Q4 ($67.7M) and said year-end 2025 net debt was comparable to year-end 2024 — a sign management contained leverage despite the loss, which limits immediate balance-sheet risk. Olin Announces Fourth Quarter 2025 Results
• Neutral Sentiment: Full Q4 earnings transcript is available — the call provides management commentary on causes of the loss, cost and pricing actions, and outlook items investors should review for guidance changes. Olin Corporation (OLN) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Top-line beat but earnings in-line/negative: revenue of $1.67B modestly beat estimates, while EPS of ($0.58) matched consensus; revenue was roughly flat year-over-year — mixed operational signals. Olin (OLN) Reports Q4 Earnings: What Key Metrics Have to Say
• Neutral Sentiment: Market/valuation note — recent analysis highlights conflicting valuation signals (high trailing P/E vs. uneven fundamentals), suggesting the stock’s current price reflects uncertainty about a near-term recovery. Is Olin (OLN) Pricing Reflect Its Mixed Share Performance And Conflicting Valuation Signals
• Negative Sentiment: Market reaction: shares fell after the wider fourth‑quarter loss and management commentary failed to reassure investors; coverage notes the quarterly loss was larger than many expected and triggered a sell-off. Olin shares tumble after wider-than-expected fourth quarter loss
• Negative Sentiment: Several outlets report the stock dropped on the Q4 results and guidance ambiguity — increased volume on the decline suggests short-term technical pressure. Olin Corporation (OLN) Stock Falls on Q4 2025 Earnings
• Negative Sentiment: Snapshot coverage emphasizes the swing from prior-year profitability to a loss, low net margin (~0.8%), and leverage metrics that keep downside risk elevated if the next quarters don’t improve. Olin: Q4 Earnings Snapshot

Olin Company Profile

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.